Leigh Disease
|
0.730 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
SDHA mutation with dominant transmission results in complex II deficiency with ocular, cardiac, and neurologic involvement.
|
27683074 |
2017 |
Leigh Disease
|
0.730 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes.
|
27604308 |
2016 |
Leigh Disease
|
0.730 |
Biomarker
|
disease |
CLINGEN |
Here, we characterize four patients with isolated complex II deficiency caused by mutations in SDHA presenting with multisystem mitochondrial disease including Leigh syndrome (LS) and/or leukodystrophy.
|
24781757 |
2015 |
Leigh Disease
|
0.730 |
GeneticVariation
|
disease |
BEFREE |
Here, we characterize four patients with isolated complex II deficiency caused by mutations in SDHA presenting with multisystem mitochondrial disease including Leigh syndrome (LS) and/or leukodystrophy.
|
24781757 |
2015 |
Leigh Disease
|
0.730 |
GeneticVariation
|
disease |
UNIPROT |
Here, we characterize four patients with isolated complex II deficiency caused by mutations in SDHA presenting with multisystem mitochondrial disease including Leigh syndrome (LS) and/or leukodystrophy.
|
24781757 |
2015 |
Leigh Disease
|
0.730 |
Biomarker
|
disease |
CLINGEN |
Only a handful of reports describe inherited SDH gene defects as a cause of paediatric mitochondrial disease, involving either SDHA (Leigh syndrome, cardiomyopathy) or SDHAF1 (infantile leukoencephalopathy).
|
22972948 |
2012 |
Leigh Disease
|
0.730 |
GeneticVariation
|
disease |
BEFREE |
Only a handful of reports describe inherited SDH gene defects as a cause of paediatric mitochondrial disease, involving either SDHA (Leigh syndrome, cardiomyopathy) or SDHAF1 (infantile leukoencephalopathy).
|
22972948 |
2012 |
Leigh Disease
|
0.730 |
Biomarker
|
disease |
CLINGEN |
SDHAF1, encoding a LYR complex-II specific assembly factor, is mutated in SDH-defective infantile leukoencephalopathy.
|
19465911 |
2009 |
Leigh Disease
|
0.730 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Leigh syndrome caused by mutations in the flavoprotein (Fp) subunit of succinate dehydrogenase (SDHA).
|
16361598 |
2006 |
Leigh Disease
|
0.730 |
Biomarker
|
disease |
CLINGEN |
Phenotypic variability of mitochondrial disease caused by a nuclear mutation in complex II.
|
16798039 |
2006 |
Leigh Disease
|
0.730 |
GeneticVariation
|
disease |
BEFREE |
The largest subunit, SDHA, is mutated in patients with Leigh syndrome and late-onset optic atrophy, but has not as yet been identified as a factor in hereditary cancer.
|
16288654 |
2005 |
Leigh Disease
|
0.730 |
Biomarker
|
disease |
CLINGEN |
Compound heterozygous mutations in the flavoprotein gene of the respiratory chain complex II in a patient with Leigh syndrome.
|
10746566 |
2000 |
Leigh Disease
|
0.730 |
GeneticVariation
|
disease |
UNIPROT |
Compound heterozygous mutations in the flavoprotein gene of the respiratory chain complex II in a patient with Leigh syndrome.
|
10746566 |
2000 |
Leigh Disease
|
0.730 |
Biomarker
|
disease |
CLINGEN |
Suppression of sdh1 mutations by the SDH1b gene of Saccharomyces cerevisiae.
|
9730279 |
1998 |
Leigh Disease
|
0.730 |
Biomarker
|
disease |
CLINGEN |
Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency.
|
7550341 |
1995 |
Leigh Disease
|
0.730 |
GeneticVariation
|
disease |
UNIPROT |
Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency.
|
7550341 |
1995 |
Leigh Disease
|
0.730 |
Biomarker
|
disease |
CLINGEN |
SDH1, the gene encoding the succinate dehydrogenase flavoprotein subunit from Saccharomyces cerevisiae.
|
1511876 |
1992 |
Leigh Disease
|
0.730 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Leigh Disease
|
0.730 |
Biomarker
|
disease |
CTD_human |
|
|
|
Gastrointestinal Stromal Tumors
|
0.700 |
GeneticVariation
|
group |
BEFREE |
We hypothesize that based on the allele frequency of SDHA and KIT mutations the tumor is best regarded as SDH-deficient GIST in which the SDHA mutation represents the most likely driver mutation.
|
31124195 |
2019 |
Gastrointestinal Stromal Tumors
|
0.700 |
GeneticVariation
|
group |
BEFREE |
Thirty per cent are associated with SDHA germline mutation and 50% are associated with SDHC epimutation (post-zygotic promoter hypermethylation) - the hallmark of the syndromic but non-hereditary Carney triad (SDH- deficient GIST, SDH-deficient paraganglioma and pulmonary chondroma).
|
29239034 |
2018 |
Gastrointestinal Stromal Tumors
|
0.700 |
GeneticVariation
|
group |
BEFREE |
An alternate mechanism leading to GIST oncogenesis is deficiency in the succinate dehydrogenase (SDH) enzyme complex resulting from genetic or epigenetic inactivation of one of the four SDH subunit genes (SDHA, SDHB, SDHC, SDHD, collectively referred to as SDHX).
|
28768491 |
2017 |
Mitochondrial Complex II Deficiency
|
0.700 |
GeneticVariation
|
disease |
CLINVAR |
SDHA related tumorigenesis: a new case series and literature review for variant interpretation and pathogenicity.
|
28546994 |
2017 |
Mitochondrial Complex II Deficiency
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
SDHA mutation with dominant transmission results in complex II deficiency with ocular, cardiac, and neurologic involvement.
|
27683074 |
2017 |
Mitochondrial Complex II Deficiency
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
SDHA related tumorigenesis: a new case series and literature review for variant interpretation and pathogenicity.
|
28546994 |
2017 |